25 Aug 2017

Kate: I’m making a difference

Kate’s mother died of acute myloid leukaemia at the age of 34, leaving behind four young children. When Kate reached the same age, she took up running and began to raise money for our cause

My mum died after a short battle with acute myeloid leukaemia. She was 34 and left four children behind – I was eight years old.

 I started running nearly three years ago, the year I turned 34. I started with 10k a month for a year, building up to half marathons last year.

I’ve always watched the London Marathon in awe, thinking I would love to do it but never thought it possible. I chose to run it for Leukaemia UK because I wanted to find a leukaemia charity that was relatively local, so that by raising money I would make a difference.

Kate completed the Great North Run and the Great South Run for Leukaemia UK in 2016, then the London Marathon and the Royal Parks Half Marathon in 2017. She raised more than £3,000 for Leukaemia UK – what an inspiration!

We are delighted that Kate has chosen to support us in memory of her mother and are so impressed with her dedication and determination. Thank you!

Read further inspiring fundraising stories, including Esther’s half marathon journey.

Read more stories from our community.

 

 

 

 

Related posts

Research Blog: A new target for paediatric AML

29 July 2026

Research Blog: A new target for paediatric AML

In May this year one of our Leukaemia UK funded John Goldman Fellows, Dr Noelia Che, published a new paper along with her colleagues: MCL1 inhibition to enhance the efficacy…

Emerging leaders accolade for former Leukaemia UK John Goldman Fellows

20 October 2023

Emerging leaders accolade for former Leukaemia UK John Goldman Fellows

Former Leukaemia UK John Goldman Fellows, Dr Matthew Blunt, University of Southampton and Dr Konstantinos Tzelepis, University of Cambridge have been recognised as ‘Emerging Leaders in Leukaemia’ by the major…

Clinical trial begins for pioneering new cancer treatment

10 January 2023

Clinical trial begins for pioneering new cancer treatment

Dr Konstantinos Tzelepis was awarded a Leukaemia UK research fellowship in 2020 and has developed a new class of cancer drug with the potential to treat leukaemia.

Only 14% of Brits know the warning signs of leukaemia as thousands are diagnosed in A&E every year.

2 September 2024

Only 14% of Brits know the warning signs of leukaemia as thousands are diagnosed in A&E every year.

Leukaemia Care and Leukaemia UK are highlighting the urgent need to raise awareness of signs and symptoms to stop the deadly blood cancer devastating lives. New research has revealed that…